I think if there was an adverse event, even in this lesser trial, it would require reporting and analysis as it is impacting patients. Management could not release what has been released and be so confident if there were unresolved safety issues IMO.
- Forums
- ASX - By Stock
- Ann: Encouraging Initial Data from CYP-006TK DFU Trial
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

I think if there was an adverse event, even in this lesser...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 0.165 |
1 | 30000 | 0.160 |
3 | 56451 | 0.155 |
5 | 136673 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 108494 | 4 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |